CN Stock MarketDetailed Quotes

301333 R&G PharmaStudies

Watchlist
  • 57.97
  • -0.10-0.17%
Market Closed Nov 4 15:00 CST
5.60BMarket Cap46.23P/E (TTM)

R&G PharmaStudies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

R&G PharmaStudies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 986.268M--
--2024/FY-- / 812.307M--
--2023/FY721.373M / 770.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 986.268M--
--2024/FY-- / 812.307M--
--2023/FY721.373M / 770.000M--
--------
--------

Unlock Free Earnings Estimates

R&G PharmaStudies Earnings Reports

  • Norsk: Third quarter 2024 report

    Oct 29 12:00 ET

  • Norsk: 2024 Semi-Annual Report

    Aug 28 12:00 ET

  • Norsk: 2024 Semi-Annual Report Summary

    Aug 28 12:00 ET

  • Norske: Annual Report 2023

    Apr 21 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 4, 2024

    Strong Buy

    • Strong Buy

      70.00%

    • Buy

      30.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data